Kanał IPHA
IP
Innate Pharma S.A.
IPHA · NASDAQ
$1.78 +0.00% (+$0.00)
1M -7.41%
Market Cap 146.0M €
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$179.54
10014.9% upside
Aktualna cena
$1.78
Niedowartościowane Wartość godziwa Przewartościowane
Valuation
0 /100
Expensive P/S 52.40x
P/FCF N/A
P/FFO N/A
Growth
0 /100
Declining Rev. growth 63.58%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak FCF margin 0.00%
Op. margin 0.00%
Gross margin 100.00%
Quality
0 /100
Poor ROA 0.00%
Asset turnover 0.04x
ROIC 0.00%
Debt
59 /100
Moderate Int. coverage -110.77x
Net debt/EBITDA 0.13x
Current ratio 1.27x
Stability
26 /100
Unstable Profitable years 0
EPS volatility 364.59%
Beta 0.88x
Zapytaj StockBota o IPHA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jonathan E. Dickinson
Employees
163
Headquarters
Marseille
Nadchodzące wydarzenia
17 WRZ
Earnings
Upcoming earnings report